Brief: Cinclus Pharma's Linaprazan Glurate Gets Marketing Approval In China
04/12/2024 14:48
Dec 4 (Reuters) - Cinclus Pharma Holding publ AB
CINPHA.ST :
* LINAPRAZAN GLURATE RECEIVES MARKETING APPROVAL IN CHINA
* APPROVAL PAVES WAY FOR COMMERCIALIZATION IN PEOPLE'S
REPUBLIC OF
CHINA IN 2025
Source text: ID:nMFN3sqkRZ
Further company coverage: CINPHA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))